IRIS
BONADONNA, Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.902
AS - Asia 9.502
EU - Europa 5.855
SA - Sud America 1.234
Continente sconosciuto - Info sul continente non disponibili 483
AF - Africa 375
OC - Oceania 10
Totale 28.361
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.580
SG - Singapore 3.539
CN - Cina 2.296
VN - Vietnam 1.389
IT - Italia 1.197
SE - Svezia 987
IE - Irlanda 969
BR - Brasile 961
HK - Hong Kong 732
BD - Bangladesh 588
UA - Ucraina 531
DE - Germania 450
FI - Finlandia 360
TR - Turchia 326
NL - Olanda 297
GB - Regno Unito 292
FR - Francia 284
ZA - Sudafrica 257
CA - Canada 200
RU - Federazione Russa 157
IN - India 134
AR - Argentina 97
IQ - Iraq 69
ES - Italia 53
MX - Messico 48
AT - Austria 47
BE - Belgio 46
ID - Indonesia 46
JP - Giappone 44
EC - Ecuador 41
PH - Filippine 40
PK - Pakistan 39
VE - Venezuela 38
KR - Corea 35
CO - Colombia 34
PL - Polonia 34
CZ - Repubblica Ceca 31
MA - Marocco 30
UZ - Uzbekistan 27
MY - Malesia 25
SA - Arabia Saudita 24
LT - Lituania 21
TH - Thailandia 19
CI - Costa d'Avorio 18
IR - Iran 18
RO - Romania 18
CL - Cile 16
JO - Giordania 16
EU - Europa 15
UY - Uruguay 15
HN - Honduras 14
PE - Perù 14
TN - Tunisia 14
KE - Kenya 13
AE - Emirati Arabi Uniti 12
TW - Taiwan 12
IS - Islanda 11
OM - Oman 10
PY - Paraguay 10
CR - Costa Rica 9
IL - Israele 9
AZ - Azerbaigian 8
BO - Bolivia 8
GT - Guatemala 8
LB - Libano 8
NI - Nicaragua 8
PT - Portogallo 8
AU - Australia 7
BG - Bulgaria 7
DO - Repubblica Dominicana 7
HU - Ungheria 7
JM - Giamaica 7
AL - Albania 6
DK - Danimarca 6
EG - Egitto 6
ET - Etiopia 6
NP - Nepal 6
RS - Serbia 6
CH - Svizzera 5
GE - Georgia 5
HR - Croazia 5
NG - Nigeria 5
DZ - Algeria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
SV - El Salvador 4
CG - Congo 3
ME - Montenegro 3
PA - Panama 3
TT - Trinidad e Tobago 3
BW - Botswana 2
BY - Bielorussia 2
BZ - Belize 2
CM - Camerun 2
GA - Gabon 2
GR - Grecia 2
IM - Isola di Man 2
KW - Kuwait 2
LV - Lettonia 2
MM - Myanmar 2
Totale 27.845
Salva come PNG Salva come JPEG
Città #
Singapore 1.727
Chandler 1.077
Ashburn 1.007
Dublin 960
San Jose 856
Dallas 828
Beijing 666
Hong Kong 665
Jacksonville 499
Council Bluffs 456
Santa Clara 454
Boardman 437
Ho Chi Minh City 427
Ann Arbor 360
Hanoi 326
Parma 304
New York 290
Izmir 266
Johannesburg 239
Nanjing 233
Los Angeles 229
Lauterbourg 224
Princeton 218
Dearborn 157
Wilmington 156
Buffalo 121
Columbus 115
San Mateo 114
Shanghai 114
Moscow 111
The Dalles 110
Toronto 102
Milan 94
Munich 92
São Paulo 86
Hefei 74
Rome 71
Kunming 70
Nanchang 68
Woodbridge 63
Da Nang 55
Shenyang 55
Helsinki 52
Frankfurt am Main 51
Seattle 51
Hebei 49
Guangzhou 44
Haiphong 43
Chicago 41
Jiaxing 41
Bologna 38
Jinan 38
Houston 36
Phoenix 36
Changsha 35
Tianjin 34
Vienna 34
Atlanta 32
Des Moines 32
Montreal 32
Rio de Janeiro 32
Tokyo 31
London 30
Brooklyn 29
Jakarta 29
Biên Hòa 28
Turku 28
Baghdad 27
Falls Church 26
Bremen 24
Brussels 24
Curitiba 24
Nuremberg 23
Warsaw 23
Hải Dương 22
Orem 22
Tashkent 22
Naples 21
Norwalk 21
San Francisco 21
Denver 20
Turin 20
Amsterdam 19
Boston 19
Chennai 19
Hillsboro 19
Istanbul 19
Seoul 19
Zhengzhou 19
Abidjan 18
Belo Horizonte 18
Ninh Bình 18
Verona 18
Hangzhou 17
Mexico City 17
Porto Alegre 17
Brno 16
Dong Ket 16
Ghent 16
Pune 16
Totale 16.162
Salva come PNG Salva come JPEG
Nome #
Pasta Structure Affects Mastication, Bolus Properties, and Postprandial Glucose and Insulin Metabolism in Healthy Adults 404
Effect of prolonged overnight fasting on energy metabolism in non-insulin-dependent diabetic and non-diabetic subjects 380
Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the area of blood glucose and insulin concentrations 265
Chronic consumption of a bergamot-based beverage does not affect glucose, lipid and inflammatory biomarkers of cardiometabolic risk in healthy subjects: a randomised controlled intervention study 244
Effect of coffee and cocoa-based confectionery containing coffee on markers of cardiometabolic health: results from the pocket-4-life project 235
Absorption, Pharmacokinetics, and Urinary Excretion of Pyridines After Consumption of Coffee and Cocoa-Based Products Containing Coffee in a Repeated Dose, Crossover Human Intervention Study 221
Claimed effects, outcome variables and methods of measurement for health claims proposed under Regulation (EC) 1924/2006 in the framework of bone health 218
Sodium-glucose cotransporter 2 inhibitors antagonize lipotoxicity in human myeloid angiogenic cells and ADP-dependent activation in human platelets: Potential relevance to prevention of cardiovascular events 216
Claimed effects, outcome variables and methods of measurement for health claims proposed under European community regulation 1924/2006 in the framework of maintenance of skin function 209
Metabolomic Changes after Coffee Consumption: New Paths on the Block 209
Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the framework of protection against oxidative damage and cardiovascular health. 207
Bioavailability of Bergamot (Citrus bergamia) Flavanones and Biological Activity of Their Circulating Metabolites in Human Pro-Angiogenic Cells 206
Claimed effects, outcome variables and methods of measurement for health claims on foods proposed under European Community Regulation 1924/2006 in the area of appetite ratings and weight management 206
How (poly)phenols can shape a healthier life? A nutri-omics investigation on their cardiometabolic health effects 205
Development and validation of an analytical hplc method to assess chemical and radiochemical purity of [68ga]ga-nodaga-exendin-4 produced by a fully automated method 204
Claimed effects, outcome variables and methods of measurement for health claims on foods proposed under Regulation (EC) 1924/2006 in the area of oral health 201
Adipocytes IGFBP-2 expression in prepubertal obese children. 195
Claimed effects, outcome variables and methods of measurement for health claims on foods related to the gastrointestinal tract proposed under regulation (EC) 1924/2006 190
Quantification of epicardial fat with cardiac CT angiography and association with cardiovascular risk factors in symptomatic patients: From the ALTER-BIO (alternative cardiovascular bio-imaging markers) registry 189
Correction: Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects(PLoS ONE (2018)12:8(e0182559) DOI: 10.1371/journal.pone.0182559) 187
Nutri-omics: how omics investigation can help designing personalized nutrition research 179
Claimed Effects, Outcome Variables and Methods of Measurement for Health Claims on Foods Related to Vision Proposed Under Regulation (EC) 1924/2006 179
Effects of TiO2 and Co3O4 Nanoparticles on Circulating Angiogenic Cells 178
Dysfunctional eating in type 2 diabetes mellitus: A multicenter Italian study of socio-demographic and clinical associations 176
Long-acting exenatide does not prevent cognitive decline in mild cognitive impairment: a proof-of-concept clinical trial 175
Effect of different patterns of consumption of coffee and a cocoa-based product containing coffee on the nutrikinetics and urinary excretion of phenolic compounds 174
A performance score of the quality of inpatient diabetes care is a marker of clinical outcomes and suggests a cause-effect relationship between hypoglycaemia and the risk of in-hospital mortality 166
Empagliflozin does not reverse lipotoxicity-induced impairment in human myeloid angiogenic cell bioenergetics 166
Effects on nitric oxide production of urolithins, gut-derived ellagitannin metabolites, in human aortic endothelial cells 165
Effect of coffee and cocoa-based confectionery containing coffee on markers of dna damage and lipid peroxidation products: Results from a human intervention study 165
A compartmental model to quantitate in vivo glucose transport in the human forearm 164
Altered homeostatic adaptation of first- and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function. 162
Hyperglycemia in the diabetic range, but not previous diagnosis of diabetes mellitus, is an independent indicator of poor outcome in patients hospitalized for severe COVID-19 160
Alterations of glucose metabolism in type 2 diabetes mellitus. An overview. 160
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 159
Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion 156
Beta-cell function across the spectrum of glucose tolerance in obese youth. 156
Associations Between Pancreatic Lipids and β-Cell Function in Black African and White European Men With Type 2 Diabetes 154
ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria 153
Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects 151
Operation of Randle's cycle in patients with NIDDM 150
Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. 150
Transcriptomic analysis of human polarized macrophages: More than one role of alternative activation? 150
A model to measure insulin effects on glucose transport and phosphorylation in muscle: a three-tracer study 150
Angiotensin-Converting Enzyme genotype and Endothelium-Dependent Vasodilation of Conduit Arteries and Forearm Microcirculation in Humans 147
Telomere length is independently associated with subclinical atherosclerosis in subjects with type 2 diabetes: a cross-sectional study 147
Claimed effects, outcome variables and methods of measurement for health claims proposed under regulation (EC) 1924/2006 and related to cognitive function in adults 143
Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins. 143
Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: A 12-month randomized controlled trial in patients with type 2 diabetes 143
Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects 141
Obesity and insulin resistance in man. A dose response study 140
Bariatric surgery or medical therapy for obesity 139
Stearic acid at physiologic concentrations induces in vitro lipotoxicity in circulating angiogenic cells 139
Bicarbonate kinetics in humans: identification and validation of athree-compartment model 138
Effect of chronic treatment with lacidipine or lisinopril on intracellular partitioning of glucose metabolism in type 2 diabetes mellitus 136
Pathogenesis of NIDDM. A balanced overview. 136
Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study). 135
Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population. 132
Evidence for early defects in insulin sensitivity and secretion before the onset of glucose dysregulation in obese youths: a longitudinal study. 132
U-shaped and J-shaped relationships between serum insulin and coronary heart disease in the general population: The Bruneck study 131
SARS-CoV-2 Spike protein is not pro-inflammatory in human primary macrophages: endotoxin contamination and lack of protein glycosylation as possible confounders 131
The Impact of Sodium Glucose Co-Transporter 2 (SGLT-2) Inhibitors on Atherogenesis: A Systematic Review of Experimental and Clinical Evidence 130
Total body fat content and fat topography are differently associated with in vivo glucose metabolism in nonobese and obese women. 130
Evaluating endothelial function of the common carotid artery: An in vivo human model. 128
Time dependence of the interaction between lipid and glucose in humans 127
Estimation of blood flow heterogeneity distribution in human skeletal muscle from positron emission tomography data 127
Microvascular complications identify a specific coronary atherosclerotic phenotype in patients with type 2 diabetes mellitus 125
Influence of cell age and keto-aminic linkage on rapid glycosylation of hemoglobin in human red cell in vitro 125
Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the framework of protection against oxidative damage and cardiovascular health 124
Phasic insulin release and metabolic regulation in type 2 diabetes 124
Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. 124
Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in nondiabetic subjects. The GISIR database. 124
The metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. 124
Predictors of insulin sensitivity in type 2 diabetes mellitus 122
Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance 122
Treatment intensification in patients with inadequate glycemic control on basal insulin: Rationale and clinical evidence for the use of short-acting and other glucagon-like peptide-1 receptor agonists 122
Intracellular glucose metabolism and insulin resistance in obese non-insulin dependent diabetes. Compensatory effects of hyperglycemia and hyperinsulinemia. 121
The Metabolic Syndrome Is a Risk Indicator of Microvascular and Macrovascular Complications in Diabetes: Results from Metascreen, a multicenter diabetes clinic-based survey. 121
Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. 121
A Novel Insulin/Glucose Model after a Mixed-Meal Test in Patients with Type 1 Diabetes on Insulin Pump Therapy 121
Association of free-living physical activity measures with metabolic phenotypes in type 2 diabetes at the time of diagnosis. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 121
Effects of a new nutraceutical formulation (Berberine, red yeast rice and chitosan) on non-HDL cholesterol levels in individuals with dyslipidemia: Results from a randomized, double blind, placebo-controlled study 121
Association of a 62 Variants Type 2 Diabetes Genetic Risk Score with Markers of Subclinical Atherosclerosis: A Transethnic, Multicenter Study 120
Variants of GCKR affect both beta cell and kidney function in patients with newly diagnosed type 2 diabetes. The Verona Newly diagnosed type diabets study (VNDS). 2. 119
Type 2 Diabetes Mellitus: a Disease of the Governance of the Glucose-Insulin System. An Experimental Metabolic Control Analysis Study. 119
Is the current therapeutic armamentarium in diabetes enough to control the epidemic and its consequences? What are the current shortcomings? 119
Metabolic interactions of amino acids and glucose in healthy humans 119
Which is the eligible patient to be treated with pioglitazone? The expert view. 118
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM 117
Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study 116
Insulin sensitivity is correlated with subcutaneous but not visceral body fat in overweight and obese prepubertal children. 116
Estimation of organ transport function for recirculating indicator dilution curves 116
Insulin resistance in essential hypertension 116
A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy 116
Insulin resistance and vasodilation in essential hypertension. Studies with adenosine 115
Metabolic and hemodynamic effects of insulin on human hearts 115
Very-low-calorie diet: a quick therapeutic tool to improve β cell function in morbidly obese patients with type 2 diabetes. 115
Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women 113
A renal genetic risk score (GRS) is associated with kidney dysfunction in people with type 2 diabetes 113
Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus 113
Totale 15.541
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.347
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.347
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022992 0 38 24 29 47 36 143 128 55 56 18 418
2022/20233.628 357 236 158 299 401 448 23 218 1.297 17 127 47
2023/20241.399 90 136 66 50 113 334 72 96 40 49 146 207
2024/20254.754 79 302 336 311 583 341 127 278 617 503 409 868
2025/202611.200 733 1.097 1.264 661 1.485 550 1.374 468 1.292 792 894 590
2026/20271.165 488 677 0 0 0 0 0 0 0 0 0 0
Totale 28.361